Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
Pfizer
Ocellaris Pharma, Inc.
Yale University
Bolt Biotherapeutics, Inc.
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
Pfizer
Numab Therapeutics AG
NuCana plc
NRG Oncology
M.D. Anderson Cancer Center
Turnstone Biologics, Corp.
Kymab Limited
Incyte Corporation
Incyte Corporation
University of California, San Diego
ImaginAb, Inc.
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
Pfizer
ADC Therapeutics S.A.
Pfizer
Vanderbilt University Medical Center
University of Florida
Novartis
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
4D pharma plc
Calithera Biosciences, Inc
Nektar Therapeutics
Duke University
Genocea Biosciences, Inc.
University of Washington
TC Biopharm
MacroGenics
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Mayo Clinic
St. Louis University